Back to Neurology
Neurologyv2019_AHA_ASAEvidence-Based

tPA (Tissue Plasminogen Activator) Contraindications for Ischemic Stroke

Evaluates eligibility and contraindications for thrombolytic therapy with IV tPA in acute ischemic stroke patients. Reviews absolute and relative contraindications based on AHA/ASA guidelines.

Clinical Input Parameters

years
Range: 0 — 120 years
Clinical Assessment
Awaiting Parameters
eligibility
—Points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The tPA (Tissue Plasminogen Activator) Contraindications for Ischemic Stroke is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Assessment of absolute and relative contraindications based on AHA/ASA guidelines

Clinical Pearls & Practice Notes

  • This tool evaluates contraindications for IV tPA (alteplase) in acute ischemic stroke
  • Time window is critical: standard window is within 3 hours, extended window 3-4.5 hours with additional exclusions
  • Absolute contraindications represent unacceptable bleeding risk
  • Relative contraindications require careful risk-benefit analysis
  • Blood pressure must be <185/110 mmHg before and during treatment
  • Always verify current institutional protocols and guidelines

Evidence & Literature Citations

  1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418.
  2. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29.
  3. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947.

Score Interpretation Ranges

Eligible≤ pts

No contraindications identified

Absolute Contraindication≤ pts

One or more absolute contraindications present

Relative Contraindication≤ pts

One or more relative contraindications present

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.